| Razaxaban | Ki | 4200.0 [1], 10000.0 [2] |
| Quercetin | IC50 | 15400.0 [1], 19000.0 [2] |
| Quercetin | Ki | 13100.0 [1] |
| Bis(5-amidino-2-benzimidazolyl)methane | IC50 | 4400.0 [1] |
| Bis(5-amidino-2-benzimidazolyl)methane | Ki | 90.0 [1], 19000.0 [2] |
| (2S)-3-(7-Carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid | IC50 | 3200.0 [1] |
| (2S)-3-(7-Carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid | Ki | 620.0 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[6-methyl-2-oxo-3-(2-phenylethylamino)pyrazin-1-yl]acetamide | IC50 | 1800.0 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[6-methyl-2-oxo-3-(2-phenylethylamino)pyrazin-1-yl]acetamide | Ki | 1800.0 [1] |
| Phenylmethylsulfonyl fluoride | IC50 | 110000.0 [1] |
| Phenylmethylsulfonyl fluoride | Ki | 10010.0 [1] |
| Dabigatran | Ki | 50.0 [1], 50.3 [2] |
| Rutin | IC50 | 16000.0 [1] |
| Rutin | Ki | 17500.0 [1] |
| Melagatran | IC50 | 11.9 [1] |
| Melagatran | Ki | 4.3 [1] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide | Ki | 60.0 [1] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride | IC50 | 100000.0 [1] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride | Ki | 60.0 [1] |
| Bms-740808 | Ki | 2800.0 [1] |
| 2-(3-Carbamimidoylphenyl)-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide | Ki | 16.0 [1] |
| Benzamidine hydrochloride hydrate | Ki | 5011.87 [1], 7943.28 [2] |
| 2-[6-Cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | IC50 | 213.0 [1] |
| 2-[6-Cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | Ki | 213000.0 [1] |
| 2-[3-(Aminomethyl)phenyl]-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide | Ki | 248.0 [1], 250.0 [2] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]acetamide | IC50 | 800.0 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]acetamide | Ki | 800.0 [1] |
| Ethyl N-[(2S)-6-amino-1-oxo-1-[5-[[4-(2-phenylethoxy)phenyl]methyl]-1,2,4-oxadiazol-3-yl]hexan-2-yl]carbamate | Ki | 190.0 [1] |
| (2S)-3-(7-Carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid;hydrochloride | Ki | 620.0 [1], 2000.0 [2] |
| (2S)-2-[[(2S)-2-[[(1R)-1-(4-Bromophenyl)ethyl]carbamoylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(2S)-5-(diaminomethylideneamino)-1-oxo-1-(1,3-thiazol-2-yl)pentan-2-yl]-3-methylbutanamide | IC50 | 12.0 [1] |
| 3-(3-Carbamimidoylphenyl)-N-[4-(2-sulfamoylphenyl)phenyl]-1,2-oxazole-4-carboxamide;2,2,2-trifluoroacetic acid | Ki | 21.0 [1] |
| 1-(3-Carbamimidoylphenyl)-N-[4-(2-sulfamoylphenyl)phenyl]pyrrole-2-carboxamide;2,2,2-trifluoroacetic acid | Ki | 56.0 [1] |
| 2-(3-Carbamimidoylphenyl)-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide;2,2,2-trifluoroacetic acid | Ki | 16.0 [1] |
| 2-(3-Carbamimidoylphenyl)-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide;2,2,2-trifluoroacetic acid | Ki | 15.0 [1] |
| Benzyl N-[(2S)-6-amino-1-oxo-1-[5-[[4-(2-phenylethoxy)phenyl]methyl]-1,2,4-oxadiazol-3-yl]hexan-2-yl]carbamate | Ki | 35.0 [1] |
| 2-[3-[(2,2-Difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | IC50 | 252.0 [1] |
| 2-[3-[(2,2-Difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | Ki | 252000.0 [1] |
| N-[(1S)-1-[4-(3-Amino-1H-indazol-6-yl)pyridin-2-yl]-2-phenylethyl]-4-(aminomethyl)cyclohexane-1-carboxamide | Ki | 64.0 [1] |
| 3-Nitrobenzamidine hydrochloride | Ki | 6309.57 [1], 79432.82 [2] |
| 3-Aminobenzenecarboximidamide | Ki | 6309.57 [1], 7943.28 [2] |
| CID 309369 | Ki | 10000.0 [1], 79432.82 [2] |
| Silymarin | IC50 | 3700.0 [1] |
| Apixaban | Ki | 4200.0 [1] |
| Baicalin | IC50 | 1000000.0 [1] |
| Argatroban | Ki | 1990.0 [1] |
| Wogonin | IC50 | 105000.0 [1] |
| Sivelestat | IC50 | 2000.0 [1] |
| Camostat | IC50 | 1.6 [1] |
| Sulfaguanidine | Ki | 1350.0 [1] |
| Oroxylin A | IC50 | 61000.0 [1] |
| 5-(N,N-Hexamethylene)amiloride | IC50 | 10000.0 [1] |
| Thromstop | IC50 | 169.0 [1] |
| Vaborbactam | IC50 | 1000000.0 [1] |
| Darexaban | Ki | 100000.0 [1] |
| Isoquinoline-1,3,4(2H)-trione | IC50 | 5000.0 [1] |
| Ganhuangenin | IC50 | 88000.0 [1] |
| Skullcapflavone II | IC50 | 110000.0 [1] |
| 1-[n-(Naphthalen-2-Ylsulfonyl)glycyl-4-Carbamimidoyl-D-Phenylalanyl]piperidine | Ki | 690.0 [1] |
| Bms-262084 | IC50 | 50.0 [1] |
| Unii-IF979jqu3S | Ki | 3290.0 [1] |
| 4-[4-(4-Amidinophenyl)piperazinyl]benzenecarboxamidine | Ki | 513.0 [1] |
| N-[(6-Amino-2-methylpyridin-3-yl)methyl]-2-[3-(benzylsulfonylamino)-6-methyl-2-oxopyridin-1-yl]acetamide | Ki | 3200.0 [1] |
| (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[3-[(4-methoxybenzoyl)amino]-2-[[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino]phenoxy]oxane-2-carboxylic acid | Ki | 100000.0 [1] |
| Letaxaban | IC50 | 60000.0 [1] |
| 2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-Aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(diaminomethylideneamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecazapentacyclo[29.20.4.07,11.013,17.043,47]pentapentacontan-40-yl]acetic acid | Ki | 0.1 [1] |
| 4-[4-(4-Carbamimidoylphenyl)-1,4-diazepan-1-yl]benzamidine | Ki | 1900.0 [1] |
| 2-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}benzenolate | Ki | 23000.0 [1] |
| alpha,alpha'-Di(amidinophenoxy)-p-xylene | Ki | 316.0 [1] |
| Unii-1Y3JD5pems | IC50 | 158000.0 [1] |
| 4-[[2-[(4-Carbamimidoylphenoxy)methyl]phenyl]methoxy]benzamidine | Ki | 221.0 [1] |
| 6-Chloro-2-(2-Hydroxybiphenyl-3-yl)-1H-Indole-5-Carboxamidine | Ki | 230.0 [1] |
| 3-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-1,1'-biphenyl-2-olate | Ki | 130.0 [1] |
| 2-(2-Hydroxyphenyl)-1H-indole-5-carboxamidine | Ki | 8000.0 [1] |
| [2-[(3,5-Dimethyl-1-phenylpyrazol-4-yl)amino]-2-oxoethyl] 2-phenylacetate | IC50 | 200000.0 [1] |
| 4-Methoxybenzenecarboximidamide | Ki | 100000.0 [1] |
| Oroxindin | IC50 | 1000000.0 [1] |
| N-[(1R,2S,5S)-2-[(5-Chloro-1H-indole-2-carbonyl)amino]-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carboxamide | Ki | 100000.0 [1] |
| Unii-FS64O4K98A | Ki | 0.3 [1] |
| Thrombin Inhibitor 2 | Ki | 202000.0 [1] |
| 3-Chloro-N-[2-[(4-fluorophenyl)carbamoyl]-4-methylphenyl]-1-benzothiophene-2-carboxamide | Ki | 5000.0 [1] |
| 3-Chloro-N-[4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl]-4-[[4,5-dihydro-1,3-oxazol-2-yl(methyl)amino]methyl]thiophene-2-carboxamide | Ki | 10000.0 [1] |
| (2R)-2-[(4-Chlorophenyl)carbamoylamino]-N-[4-(3-oxomorpholin-4-yl)phenyl]pentanamide | IC50 | 10000.0 [1] |
| Bms-344577 | Ki | 10000.0 [1] |
| 1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide | IC50 | 352000.0 [1] |
| 1-[[5-(5-Chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-N-(1-propan-2-ylpiperidin-4-yl)indole-2-carboxamide | Ki | 100000.0 [1] |
| Benzo[b]thiophene-2-carboxamide,3-chloro-N-[2-[[(4-chlorophenyl)amino]carbonyl]-4-methylphenyl]- | Ki | 5000.0 [1] |
| 2-Benzylsulfonylguanidine | Ki | 1350.0 [1] |
| ({3-[3-(5-Carbamimidoyl-1H-1,3-benzodiazol-2-yl)-2-hydroxyphenyl]-4-hydroxyphenyl}methyl)urea | Ki | 3600.0 [1] |
| 3-[[2-[(6R)-6-[(5-Chloro-2-methoxyphenyl)methyl]-3-(2,2-dimethylhydrazinyl)-7-oxo-5,6-dihydro-2H-1,4-diazepin-1-yl]acetyl]amino]benzoic acid;hydrochloride | IC50 | 30000.0 [1] |
| Amido phenyl pyruvic acid | Ki | 10000.0 [1] |
| 6-[4-[2-[[(3R)-3-Hydroxypyrrolidin-1-yl]methyl]phenyl]phenyl]-1-(4-methoxyphenyl)-3-(trifluoromethyl)-4,5-dihydropyrazolo[3,4-c]pyridin-7-one | Ki | 3000.0 [1] |
| (3S)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[1-(cyclopropylamino)-5,5-difluoro-1,2-dioxopentan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide | Ki | 50000.0 [1] |
| N-(3-Chloro-benzyl)-2-(6-methyl-2-oxo-3-phenylmethanesulfonylamino-2H-pyridin-1-yl)-acetamide | Ki | 20000.0 [1] |
| 3-[2-(5-Chlorothiophen-2-yl)-3H-benzimidazol-5-yl]-N-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]propanamide | IC50 | 10000.0 [1] |
| 4-(Hydroxymethyl)benzamidine | Ki | 79432.82 [1] |
| 6-[1-[(2S)-3-(6-Chloronaphthalen-2-yl)sulfonyl-2-hydroxypropanoyl]piperidin-4-yl]-3-methyl-7H-imidazo[1,5-c]imidazol-5-one | Ki | 60000.0 [1] |
| Unii-XD269G3O31 | Ki | 8000.0 [1] |
| 3-[6-[4-[2-[(Dimethylamino)methyl]phenyl]phenyl]-7-oxo-3-(trifluoromethyl)-4,5-dihydropyrazolo[3,4-c]pyridin-1-yl]benzamide | Ki | 1800.0 [1] |
| N-[2-(Diaminomethylideneamino)oxyethyl]-2-[3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]acetamide | Ki | 128.0 [1] |
| 2-(1-Aminoisoquinolin-7-yl)-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide | Ki | 2600.0 [1] |